These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23665729)

  • 1. Clinical and cost-effectiveness of absorbent dressings in the treatment of highly exuding VLUs.
    Panca M; Cutting K; Guest JF
    J Wound Care; 2013 Mar; 22(3):109-10, 112-8. PubMed ID: 23665729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Clinical and cost-effectiveness of absorbent dressings in the treatment of highly exuding VLUs'.
    Bishop S; Rolley J
    J Wound Care; 2013 Nov; 22(11):644, 646. PubMed ID: 24225605
    [No Abstract]   [Full Text] [Related]  

  • 3. Relative cost-effectiveness of a skin protectant in managing venous leg ulcers in the UK.
    Guest JF; Taylor RR; Vowden K; Vowden P
    J Wound Care; 2012 Aug; 21(8):389-94, 396-8. PubMed ID: 22885312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of using carboxymethylcellulose dressing compared with gauze in the management of exuding venous leg ulcers in Germany and the USA.
    Guest JF; Ruiz FJ; Mihai A; Lehman A
    Curr Med Res Opin; 2005 Jan; 21(1):81-92. PubMed ID: 15881478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-effectiveness analysis of a hydration response technology dressing in the treatment of venous leg ulcers in the UK.
    Walzer S; Dröschel D; Vollmer L; Atkin L; Ousey K
    J Wound Care; 2018 Mar; 27(3):166-172. PubMed ID: 29509113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and cost-effectiveness of three alternative compression systems used in the management of venous leg ulcers.
    Guest JF; Gerrish A; Ayoub N; Vowden K; Vowden P
    J Wound Care; 2015 Jul; 24(7):300, 302-5, 307-8, passim. PubMed ID: 26198552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes and cost-effectiveness of an externally applied electroceutical device in managing venous leg ulcers in clinical practice in the UK.
    Guest JF; Ayoub N; Greaves T
    J Wound Care; 2015 Dec; 24(12):572, 574-80. PubMed ID: 26654737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes and cost-effectiveness of three different compression systems in newly-diagnosed venous leg ulcers in the UK.
    Guest JF; Fuller GW; Vowden P
    J Wound Care; 2017 May; 26(5):244-254. PubMed ID: 28475441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous leg ulcer management in clinical practice in the UK: costs and outcomes.
    Guest JF; Fuller GW; Vowden P
    Int Wound J; 2018 Feb; 15(1):29-37. PubMed ID: 29243398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the cost-effectiveness of electric stimulation therapy in non-healing venous leg ulcers.
    Taylor RR; Sladkevicius E; Guest JF
    J Wound Care; 2011 Oct; 20(10):464, 466, 468-72. PubMed ID: 22067884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reply: To PMID 23665729.
    Panca M; Cutting KF; Guest JF
    J Wound Care; 2013 Nov; 22(11):646-8. PubMed ID: 24288785
    [No Abstract]   [Full Text] [Related]  

  • 12. Modelling the relative cost-effectiveness of amelogenin in non-healing venous leg ulcers.
    Guest JF; Nagy E; Sladkevicius E; Vowden P; Price P
    J Wound Care; 2009 May; 18(5):216, 218-24. PubMed ID: 19440174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the Clinical Outcomes and Cost Differences Between Standard Care With and Without Cadexomer Iodine in the Management of Chronic Venous Leg Ulcers Using a Markov Model.
    Nherera LM; Woodmansey E; Trueman P; Gibbons GW
    Ostomy Wound Manage; 2016 Jun; 62(6):26-40. PubMed ID: 27356144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of using a collagen-containing dressing plus compression therapy in non-healing venous leg ulcers.
    Guest JF; Rana K; Singh H; Vowden P
    J Wound Care; 2018 Feb; 27(2):68-78. PubMed ID: 29424641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative cost-effectiveness of three compression bandages in treating newly diagnosed venous leg ulcers in the UK.
    Guest JF; Fuller GW
    J Wound Care; 2023 Mar; 32(3):146-158. PubMed ID: 36930185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of primary dressings on healing of venous leg ulcers: a French cohort study from the healthcare insurance database.
    Meaume S; Senet P; Thomé B; Aragno VA; Serge B; Fortin S; Boucley I; Michon-Pasturel U; Colboc H
    J Wound Care; 2024 Sep; 33(9):678-686. PubMed ID: 39287032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superabsorbent wound dressings versus foams dressings for the management of moderate-to-highly exuding venous leg ulcers in French settings: An early stage model-based economic evaluation.
    Veličković VM; Prieto PA; Krga M; Jorge AM
    J Tissue Viability; 2022 Aug; 31(3):523-530. PubMed ID: 35534319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of three adjunct cellular/tissue-derived products used in the management of chronic venous leg ulcers.
    Carter MJ; Waycaster C; Schaum K; Gilligan AM
    Value Health; 2014 Dec; 17(8):801-13. PubMed ID: 25498775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling the cost implications of using carboxymethylcellulose dressing compared with gauze in the management of surgical wounds healing by secondary intention in the US and UK.
    Guest JF; Ruiz FJ
    Curr Med Res Opin; 2005 Feb; 21(2):281-90. PubMed ID: 15801999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effective use of silver dressings for the treatment of hard-to-heal chronic venous leg ulcers.
    Jemec GB; Kerihuel JC; Ousey K; Lauemøller SL; Leaper DJ
    PLoS One; 2014; 9(6):e100582. PubMed ID: 24945381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.